Cystic fibrosis precision therapeutics: Emerging considerations
Sign Up to like & getrecommendations! Published in 2019 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.24547
Abstract: Small molecules that address fundamental defects underlying cystic fibrosis (CF), including modulators such as the approved drugs ivacaftor, lumacaftor, tezacaftor, and elexacaftor, have advanced dramatically over the past few years and are transforming care and… read more here.
Keywords: cystic fibrosis; fibrosis; therapeutics emerging; precision therapeutics ... See more keywords
EBV-associated diseases: Current therapeutics and emerging technologies
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1059133
Abstract: EBV is a prevalent virus, infecting >90% of the world’s population. This is an oncogenic virus that causes ~200,000 cancer-related deaths annually. It is, in addition, a significant contributor to the burden of autoimmune diseases.… read more here.
Keywords: therapeutics emerging; emerging technologies; ebv associated; associated diseases ... See more keywords